Search for: "PFIZER" Results 4021 - 4040 of 4,635
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Apr 2022, 7:48 am by Paul Stephan
Pundits have reveled in the prospect of using the Russian central bank funds currently frozen by the U.S. [read post]
31 Dec 2020, 11:41 pm by Florian Mueller
Pfizer/BioNTech offered the EU 500 million doses, and Moderna (which uses the same type of technique, mRNA) another 300 million. [read post]
20 Jan 2022, 6:01 am by Tanner Larkin
All 21 of the defendants belong to the corporate families AstraZeneca, GE Healthcare, Johnson & Johnson, Pfizer or Roche. [read post]
2 Mar 2012, 6:52 am by Bexis
Pfizer (femoral stem) Deposition1998-06-30 Suerth v. [read post]
9 Aug 2012, 5:00 am by Bexis
Pfizer (femoral stem) Deposition1998-06-30 Suerth v. [read post]
9 Apr 2021, 8:03 am by Lisa Larrimore Ouellette
The mRNA platform used by the Moderna and Pfizer-BioNTech vaccines is exciting in part because the vaccines can be produced more quickly than with older technologies, but a key bottleneck has been the small number of facilities that can make lipid nanoparticles for encapsulating the mRNA. [read post]
26 Jul 2019, 11:18 am
In particular, the Dutch District Court of The Hague’s decision that tromethamine cannot be considered equivalent to disodium in contrast to many other national courts.GuestKat Rose Hughes summarised the appeal in J 05/18 and in particular the finding that an isolated error in a well-functioning system is not equivalent to all due care.This was followed up with a further post from Rose on the refusal of Mr Justice Birss to grant an arrow declaration in… [read post]
1 Aug 2019, 2:14 am
Earlier this year, the UK courts considered the validity of Genentech's patent for Taltz, an anti-IL-17 monoclonal antibody (IPKat post here), and last month, the courts considered Pfizer's request for an Arrow declaration relating to Roche's monoclonal antibody drug Avastin (bevacizumab) (IPKat post here).The latest UK High Court patent decision (Takeda v Roche [2019] EWHC 1911) relates to another pair of pharmaceutical company giants (Takeda and Roche), and… [read post]
6 Feb 2015, 6:31 am
 The first was the Minutes of  Meeting of the North of Tyne Area Prescribing Committee (“APC”) on 13 January 2015 which extraordinarily concluded as follows:Pfizer have contacted CCGs and community pharmacies to highlight that they believe the supply of generic pregabalin for use in the treatment of pain, whilst the pain patent remains in force in the UK, would infringe Pfizer’s patent rights. [read post]
21 Nov 2020, 7:04 am by Lisa Larrimore Ouellette
Sherkow, and Lisa Larrimore OuellettePromising results for the Pfizer/BioNTech and Moderna vaccines have been the most exciting COVID-19 innovation news in the past few weeks. [read post]
23 Nov 2015, 2:40 pm
 ****************** PREVIOUSLY, ON NEVER TOO LATE Never Too Late 72 [week ending on Sunday 15 November] –  Merck Sharp & Dohme v Ono Pharmaceutical | Warner-Lambert Co LLC v Sandoz GmbH, Sandoz Ltd and Lloyds Pharmcacy Ltd | Economics of internet trolls | UK IPO scammer scammed | Video conferencing at the EPO | Warner-Lambert v Pfizer in France | African Ministerial Conference in IP | Green claims and branding | CJEU… [read post]
30 Jul 2019, 9:04 am
| BEAUTY & THE BAY not an infringement of BEAUTY BAY, says High Court | US copyright registration for the Tommy Hilfiger Flag denied due to insufficient originality | The reemergence of issues surrounding copyright and the Australian Aboriginal Flag… | Gigi Hadid, Smile for the Copyright | Eli Lilly v Fresenius Kabi: a decision far from equivalent to what has been decided before | Re-establishment: An isolated error in a well-functioning system may not be equivalent to all due care (J… [read post]
7 Feb 2020, 12:43 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
20 Oct 2015, 1:11 pm
Oct. 5, 2015), the Court of Common Pleas considered defendant Pfizer’s motions to  exclude the testimony of plaintiffs’ causation experts. [read post]
6 Dec 2021, 6:24 am by Lisa Larrimore Ouellette
Phase 2/3 clinical trials began in February 2021 for Pfizer/BioNTech and Janssen and included pregnant people. [read post]